Conagra Brands shares slip on quarterly earnings miss

Conagra Brands (NYSE:CAG) shares declined 4.7% after reporting fiscal fourth-quarter results below Wall Street estimates, with revenue down 4.3% year-over-year to $2.78 billion and adjusted EPS falling 8.2% to $0.56. The company attributed the miss to ongoing supply constraints, higher inflation, and macroeconomic uncertainty. Conagra also provided a cautious fiscal 2026 outlook, projecting organic net sales growth of -1% to 1% and adjusted EPS of $1.70-$1.85, significantly below analyst consensus, indicating persistent headwinds.

Analysis

Conagra Brands (CAG) reported a notable miss for its fiscal fourth quarter, with revenue declining 4.3% year-over-year to $2.78 billion, falling short of consensus estimates of $2.83-$2.88 billion. Adjusted EPS also underperformed, dropping 8.2% to $0.56 against a consensus of $0.61. The company attributed this weakness to a combination of higher-than-expected inflation, adverse foreign exchange movements, and ongoing supply constraints, indicating broad operational and macroeconomic pressures. Critically, the company's forward guidance for fiscal 2026 signals these challenges are expected to persist. Conagra projects stagnant organic net sales growth between -1% and 1% and a full-year adjusted EPS of $1.70-$1.85. This EPS guidance is significantly below the Street's consensus of $2.13-$2.21, implying that analysts' models were overly optimistic and a substantial earnings reset is now underway, justifying the immediate 4.7% decline in its share price.

Key Decisions for Investors

• Given the significant miss on both current earnings and forward guidance, investors should anticipate downward revisions to analyst price targets and earnings estimates for fiscal 2026.
• The weak guidance for both sales (-1% to 1%) and EPS ($1.70-$1.85) suggests the headwinds from inflation and supply chain issues are not abating, warranting a cautious stance until there is evidence of operational improvement or margin stabilization.
• For long-term holders, it is critical to weigh the CEO’s unchanged long-term strategy against the clear near-term deterioration in fundamentals; trimming positions may be prudent until the earnings outlook becomes more certain.